Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype

Yongqing Liu1, Brian Clem, Ewa K Zuba-Surma

  • 1Molecular Targets Program, Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, KY 40202, USA.

Cell Stem Cell
|April 4, 2009
PubMed

Insights

Loss of RB1 pathway function causes cell outgrowth, generating cancer stem cells. This suggests RB1

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • The RB1 pathway is crucial for cell-cycle arrest and contact inhibition.
  • Mutations in RB1 family members disrupt these processes, leading to uncontrolled cell growth.
  • Contact inhibition normally prevents excessive cell proliferation in differentiated somatic cells.

Purpose of the Study:

  • To investigate the role of RB1 pathway-mediated contact inhibition in preventing cancer stem cell generation.
  • To explore how bypassing contact inhibition in RB1-mutated cells affects cellular reprogramming.
  • To understand the tumor suppressor function of RB1 in the context of cancer stem cell formation.

Main Methods:

  • Fibroblast cell culture and manipulation of RB1 gene status.
  • Induction of cell-cell contact and sphere formation in suspension culture.
  • Tumorigenicity assays in nude mice.
  • Analysis of cell differentiation and stem cell properties.

Main Results:

  • Complete RB1 mutation led to loss of contact inhibition and fibroblast outgrowth into spheres.
  • These outgrowing cells exhibited cancer stem cell properties, forming tumors and differentiating.
  • Even with partial RB1 mutation, forcing sphere formation bypassed contact inhibition and generated cancer stem cells.

Conclusions:

  • RB1 pathway-mediated contact inhibition acts as a tumor suppressor by preventing the generation of cancer stem cells from differentiated somatic cells.
  • Loss of RB1 function and subsequent cell outgrowth create conditions conducive to cancer stem cell formation.
  • Maintaining contact inhibition is critical for preventing the acquisition of cancer stem cell characteristics in advancing cancers.